Showing 1891-1900 of 3276 results for "".
Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
https://practicaldermatology.com/programs/cme/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
https://practicaldermatology.com/programs/cme/data-driving-preferred-guideline-recommendations-in-first-line-therapy-for-metastatic-melanoma/36327/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
https://practicaldermatology.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
https://practicaldermatology.com/programs/cme/insights-from-global-key-opinion-leaders-on-regional-regulatory-and-guideline-nuances-to-optimize-melanoma-management/36331/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Acne Scars: Optimizing Treatment with Devices and Combinations
https://practicaldermatology.com/topics/practice-management/acnescarsoptimizingtreatmentwithdevicesand-combinations/20542/Multiple factors affect the selection of a treatment for acne scars. Best outcomes are possible with a combination of approaches.Best-in-Class At-Home Beauty Devices for Dermatologists
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/best-in-class-at-home-beauty-devices-for-dermatologists/20724/An experience-based assessment of a growing market segment.Take a Load Off Your Back: A How-To Guide
https://practicaldermatology.com/topics/practice-management/take-a-load-off-your-back-a-how-to-guide/22076/Dermatologic surgeons spend their days bent over exam tables to perform procedures. Their backs may suffer.Reassessing Topical 5-Fluorouracil for AK Management
https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.The Importance of Diversity in Clinical Trials
https://practicaldermatology.com/issues/april-2025/the-importance-of-diversity-in-clinical-trials/35606/The disproportionate representation of certain segments of the population in clinical trials is no secret, and research has shown that psoriasis studies are the least racially diverse of all dermatology studies in the US.